MANWANI HARISH 4
4 · GILEAD SCIENCES, INC. · Filed May 6, 2022
Insider Transaction Report
Form 4
MANWANI HARISH
Director
Transactions
- Award
Common Stock
2022-05-05+2,444→ 9,972 total - Tax Payment
Common Stock
2022-05-05$61.35/sh−477$29,264→ 9,495 total - Award
Non-qualified Stock Option (Right to Buy)
2022-05-05+15,851→ 15,851 totalExercise: $61.35Exp: 2032-05-05→ Common Stock (15,851 underlying)
Footnotes (2)
- [F1]Represents 2,444 restricted stock units ("RSUs") granted under the Gilead Sciences, Inc. 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. The RSUs vested immediately upon the grant date of May 5, 2022.
- [F2]100% of the shares subject to the stock option vested immediately upon the grant date of May 5, 2022.